分子影像技术用于视网膜疾病研究进展  

Research advancements of molecular imaging technology for retinal diseases

作　　者：陈媛 王柯[2] 杨敏 CHEN Yuan;WANG Ke;YANG Min(Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing 211166, China;NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China)

机构地区：[1]南京医科大学药学院核药学系,江苏南京211166 [2]国家卫生健康委员会核医学重点实验室,江苏省分子核医学重点实验室,江苏省原子医学研究所,江苏无锡214063

出　　处：《中国介入影像与治疗学》2022年第5期314-317,共4页Chinese Journal of Interventional Imaging and Therapy

基　　金：江苏省科技项目(BK20192005)。

摘　　要：分子影像技术是传统医学影像学技术与现代分子生物学结合而产生的新兴成像技术,可基于生物分子水平显示体内正常及异常生物进程,现已用于研究视网膜疾病。本文基于视网膜疾病发病机制,对分子影像技术用于视网膜疾病的研究进展进行综述。Molecular imaging technology is a new imaging technology produced by the combination of traditional medical imaging technology and modern molecular biology,which can display normal and abnormal biological processes of body based on biomolecular level,hence having been used in the research of retinal diseases.Based on the pathogenesis,the research advancements of molecular imaging technology in retinal diseases were reviewed in this article.

关 键 词：视网膜疾病 分子成像 

分 类 号：R774.1[医药卫生—眼科] R445[医药卫生—临床医学]